Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 26;29(1):21-38.
doi: 10.1515/revneuro-2017-0036.

Genetic underpinnings in Alzheimer's disease - a review

Affiliations
Free article

Genetic underpinnings in Alzheimer's disease - a review

Ahmed A Moustafa et al. Rev Neurosci. .
Free article

Erratum in

  • Corrigendum to: Genetic underpinnings in Alzheimer's disease - a review.
    Moustafa AA, Hassan M, Hewedi DH, Hewedi I, Garami JK, Al Ashwal H, Zaki N, Seo SY, Cutsuridis V, Angulo SL, Natsheh JY, Herzallah MM, Frydecka D, Misiak B, Salama M, Mohamed W, El Haj M, Hornberger M. Moustafa AA, et al. Rev Neurosci. 2018 Sep 25;29(7):815. doi: 10.1515/revneuro-2018-0081. Rev Neurosci. 2018. PMID: 30179856 No abstract available.

Abstract

In this review, we discuss the genetic etiologies of Alzheimer's disease (AD). Furthermore, we review genetic links to protein signaling pathways as novel pharmacological targets to treat AD. Moreover, we also discuss the clumps of AD-m ediated genes according to their single nucleotide polymorphism mutations. Rigorous data mining approaches justified the significant role of genes in AD prevalence. Pedigree analysis and twin studies suggest that genetic components are part of the etiology, rather than only being risk factors for AD. The first autosomal dominant mutation in the amyloid precursor protein (APP) gene was described in 1991. Later, AD was also associated with mutated early-onset (presenilin 1/2, PSEN1/2 and APP) and late-onset (apolipoprotein E, ApoE) genes. Genome-wide association and linkage analysis studies with identified multiple genomic areas have implications for the treatment of AD. We conclude this review with future directions and clinical implications of genetic research in AD.

Keywords: AChE; APP; Alzheimer’s disease; BChE; amyloid-β; genetics; presenilin; prevalence vs. penetrance of genes.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances